Works Cited

1. Erickson W, Lee C., von Schrader S. 2018 Disability Status Report: United States. Ithaca, NY: Cornell University Yang-Tan Institute on Employment and Disability; 2020.

2. Administration for Community Living. 2020 Profile of Older Americans. Available at Last accessed April 9, 2022.

3. Sjögren's Syndrome Foundation. Diagnosis. Available at Last accessed April 9, 2022.

4. Sjögren's Foundation. Understanding Sjögren's. Available at Last accessed April 9, 2022.

5. Rosengard HC. Oral Manifestations of Systemic Diseases. Available at Last accessed April 9, 2022.

6. Radke LM. Pre-radiation therapy dental evaluation. Greater Milwaukee Dental Association Journal. 1996;63(4):104-109.

7. Plemons JM, Al-Hashimi I, Marek CL. American Dental Association Council on Scientific Affairs. Managing xerostomia and salivary gland hypofunction: executive summary of a report from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc. 2014;145(8):867-873.

8. Ranatunga SK. How is Oral Candidiasis Treated in Sjögren Syndrome? Available at Last accessed April 9, 2022.

9. Little JW, Miller CS, Rhodus NL. Little and Falace'sDental Management of the Medically Compromised Patient. 9th ed. St. Louis, MO: Mosby; 2017.

10. Laudenbach JM, Ship JA. Clinician's Guide to Oral Health in Geriatric Patients. 3rd ed. Edmonds, WA: American Academy of Oral Medicine; 2011.

11. Jonsson R, Vogelsang P, Volchenkov R, Espinosa A, Wahren-Herlenius M, Appel S. The complexity of Sjögren's syndrome: novel aspects of pathogenesis. Immunol Lett. 2011;141(1):1-9.

12. González S, Sung H, Sepúlveda D, González M, Molina C. Oral manifestations and their treatment in Sjögren's syndrome. Oral Dis. 2014;20(2):153-161.

13. Rekvig OP, Van der Vlag J. The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved. Semin Immunopathol. 2014;36(3):301-311.

14. Scully C, Flint SR, Bagan JV, Porter SR, Moos KF. Oral and Maxillofacial Diseases: An Illustrated Guide to Diagnosis and Management of Diseases of the Oral Mucosa, Gingivae, Teeth, Salivary Glands, Bones, and Joints. 4th ed. London: Informa Healthcare; 2010.

15. Weckerle CE, Niewold TB. The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies. Clin Rev Allergy Immunol. 2011;40(1):42-49.

16. Hersh AO, Trupin L, Yazdany J, et al. Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2010;62(8):1152-1159.

17. Souza DCC, Santo AH, Sato EI. Mortality profile related to systemic lupus erythematosus: a multiple cause-of-death analysis.J Rheumatol. 2012;39(3):496-503.

18. Thomas G, Mancini J, Jourde-Chiche N, et al. Mortality associated with systemic lupus erythematosus in France assessed by multiple-cause-of-death analysis. Arthritis Rheumatol. 2014;66(9):2503-2511.

19. Petri M. Life-threatening complications of systemic lupus erythematosus. In: Khamashta MA, Ramos-Casals M (eds). Autoimmune Diseases: Acute and Complex Situations. London: Springer-Verlag; 2011: 9-17.

20. American Dental Association. American Dental Association Guide to Dental Therapeutics. 5th ed. Chicago, IL: American Dental Association; 2009.

21. Wynn RL, Meiller TF, Crossley HL. Drug Information Handbook for Dentistry. 27th ed. Hudson, OH: Lexi-Comp; 2021.

22. RxList. Cytoxan. Available at Last accessed April 19, 2022.

23. Shetti A, Gupta I, Charantimath SM. Oral candidiasis: aiding in the diagnosis of HIV: a case report. Case Rep Dent. 2011;929616.

24. American Dental Association. Human Immunodeficiency Virus (HIV). Available at science-and-research-institute/oral-health-topics/hiv. Last accessed April 18, 2022.

25. Scully C. Medical Problems in Dentistry. 7th ed. Edinburgh: Churchill Livingstone Elsevier; 2014.

26. Suzuki JB, Chialastri SM. Dental implications for the immunocompromised organ transplant patient. Grand Rounds in Oral- Systemic Medicine. 2007;2(3):36-44.

27. Boltchi FE, Rees TD, Iacopino AM. Cyclosporine A-induced gingival overgrowth: a comprehensive review. Quintessence Int. 1999;30(11):775-783.

28. LexiComp Online. Available at Last accessed April 18, 2022.

29. Muñoz P, Giannella M, Burillo A, Bouza E. Aspergillus and other mold infections after solid organ transplant. In: Bowden RA, Ljungman P, Snydman DR (eds). Transplant Infections. 3rd ed. China: Lippincott Williams & Wilkins; 2012: 554-585.

30. Centers for Disease Control and Prevention. Fungal Diseases: Treatment for Aspergillosis. Available at fungal/diseases/aspergillosis/treatment.html. Last accessed April 18, 2022.

31. Hall EC, Pfeiffer RM, Segev DL, Engels EA. Cumulative incidence of cancer after solid organ transplantation. Cancer. 2013;119(12):2300-2308.

32. Tessari G, Naldi L, Boschiero L, et al. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study. Arch Dermatol. 2010;146(3):294-299.

33. Madeleine MM, Finch JL, Lynch CF, Goodman MT, Engels EA. HPV-related cancers after solid organ transplantation in the United States. Am J Transplant. 2013;13(12):3202-3209.

34. Rhodus NL, Little JW. Dental management of the bone marrow transplant patient. Compendium. 1992;13(11):1040, 1042-1050.

35. Newman MG, van Winkelhoff AJ. Antibiotic and Antimicrobial Use in Dental Practice. 2nd ed. Carol Stream, IL: Quintessence Publishing Co Inc.; 2001.

36. Organ Procurement and Transplantation Network. Special Issue: OPTN/SRTR Annual Data Report 2014. Am J Transplant. 2016;16(Suppl S2):4-215.

37. DeMaagd G, Philip A. Parkinson's disease and its management. Part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. PT. 2015;40(8):504-510, 532.

38. Schapira AH. Treatment options in the modern management of Parkinson disease. Arch Neurol. 2007;64(8):1083-1088.

39. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality—1967. Neurology. 1998;50(2):318-334.

40. Kalf JG, de Swart BJ, Borm GF, Bloem BR, Munneke M. Prevalence and definition of drooling in Parkinson's disease: a systematic review. J Neurol. 2009;256(9):1391-1396.

41. Korchounov A, Kessler KR, Schipper HI. Differential effects of various treatment combinations on cardiovascular dysfunction in patients with Parkinson's disease. Acta Neurol Scand. 2004;109(1):45-51.

42. Prevalence and Incidence of Cerebral Palsy. Available at Last accessed April 18, 2022.

43. Rosenbaum P, Paneth N, Leviton A, et al. A report: the definition and classification of cerebral palsy, April 2006. Dev Med Child Neurol Suppl. 2007;109:8-14.

44. Sehrawat N, Marwaha M, Bansal K, Chopra R. Cerebral palsy: a dental update. Int J Clin Pediatr Dent. 2014;7(2):109-118.

45. National Spinal Cord Injury Statistical Center. Spinal Cord Injury Facts and Figures At A Glance, 2020. Available at Last accessed April 19, 2022.

46. University of Florida College of Dentistry. Oral Care for Persons with Disabilities: Traumatic Injuries. Available at Last accessed April 19, 2022.

47. Tran P, Mannen J. Improving oral healthcare: improving the quality of life for patients after a stroke. Spec Care Dentist. 2009;29(5):218-221.

48. Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation. 2019;139:e1-e473.

49. National Center for Health Statistics. Leading Causes of Death. Available at Last accessed April 19, 2022.

50. Henry RG, Smith BJ. Managing older patients who have neurologic disease: Alzheimer disease and cerebrovascular accident.Dent Clin N Am. 2009;53(2):269-294.

51. Paolucci S. Epidemiology and treatment of post-stroke depression. Neuropsychiatr Dis Treat. 2008;4(1):145-154.

52. Napenas JJ, Hong CHL, Brennan MT, Furney SL, Fox PC, Lockhart PB. The frequency of bleeding complications after invasive dental treatment in patients receiving single and dual antiplatelet therapy. J Am Dent Assoc. 2009;140(6):690-695.

53. American Dental Association. Anticoagulant and Antiplatelet Medications and Dental Procedures. Available at Last accessed April 19, 2022.

54. Gulati G, Hevelow M, George M, Behling E, Siegel J. International normalized ratio versus plasma levels of coagulation factors in patients on vitamin K antagonist therapy. Arch Pathol Lab Med. 2011;135(4):490-494.

55. Powell-Hamilton NN. Down Syndrome (Trisomy 21; Trisomy G). Available at Last accessed April 19, 2022.

56. National Down Syndrome Society. Down Syndrome Facts. Available at Last accessed April 19, 2022.

57. National Institute of Dental and Craniofacial Research. Practical Oral Care for People with Down Syndrome. Available at Last accessed April 19, 2022.

58. Cheng RHW, Yiu CKY, Leung WK. Oral health in individuals with Down syndrome. In: Dey S (ed). Prenatal Diagnosis and Screening for Down Syndrome. Rijeka: InTech; 2011: 59-76.

59. Izumi Y, Sugiyama S, Shinozuka O, Yamazaki T, Ohyama T, Ishikawa I. Defective neutrophil chemotaxis in Down's syndrome patients and its relationship to periodontal destruction. J Periodontol. 1989;60(5):238-242.

60. Khocht A. Down syndrome and periodontal disease. In: Dey S (ed). Genetics and Etiology of Down Syndrome. Rijeka: InTech;209-230.

61. Yavuzyilmaz E, Ersoy F, Sanal O, Tezcan I, Erçal D. Neutrophil chemotaxis and periodontal status in Down's syndrome patients.J Nihon Univ Sch Dent. 1993;35(2):91-95.

62. Whittingham S, Pitt DB, Sharma DL, Mackay IR. Stress deficiency of the T-lymphocyte system exemplified by Down syndrome. Lancet. 1977;1(8004):163-166.

63. Bagić I, Verzak Z, Cuković-Cavka S, Brkić H, Susić M. Periodontal conditions in individuals with Down's syndrome. Coll Antropol. 2003;27(Suppl 2):75-82.

64. Hennequin M, Faulks D, Veyrune JL, Bourdiol P. Significance of oral health in persons with Down syndrome: a literature review. Dev Med Child Neurol. 1999;41(4):275-283.

65. Alzheimer's Association. Alzheimer's Facts and Figures. Available at Last accessed April 19, 2022.

66. Alzheimer's Association. 2018 Alzheimer's disease facts and figures. Alzheimers Dement. 2018;14(3):367-429.

67. Alzheimer's Association. What is Alzheimer's Disease? Available at Last accessed April 19, 2022.

68. Seely WW, Miller B. Alzheimer's disease and other dementias. In: Hauser SL, Josephson SA (eds). Harrison's Neurology in Clinical Medicine. 4th ed. New York, NY: McGraw-Hill; 2017: 392-407.

69. Sloane PD, Kaufer DI. Alzheimer's disease. In: Kellerman RD, Rakel D (eds). Conn's Current Therapy 2019. Philadelphia, PA: Elsevier; 2019: 673-677.

70. Tektonidou MG, Lewandowski LB, Dasgupta A, Ward MM. Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016. Ann Rheum Dis. 2017;76(12):2009-2016.

71. Robinson RG, Jorge RE. Post-stroke depression: a review. Am J Psychiatry. 2016;173(3):221-231.

Evidence-Based Practice Recommendations Citations

1. Zero DT, Brennan MT, Daniels TE, et al. Clinical practice guidelines for oral management of Sjögren disease: dental caries prevention.J Am Dent Assoc. 2016;147(4):295-305. Available at Last accessed April 21, 2022.

2. Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV: Recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Available at Last accessed April 21, 2022.

3. National Institute for Health and Care Excellence. Parkinson's Disease in Adults. Available at Last accessed April 21, 2022.

Copyright © 2022 NetCE, P.O. Box 997571, Sacramento, CA 95899-7571
Mention of commercial products does not indicate endorsement.